STAAR Surgical
STAA
#5688
Rank
C$1.60 B
Marketcap
C$32.61
Share price
-7.25%
Change (1 day)
-12.29%
Change (1 year)

P/E ratio for STAAR Surgical (STAA)

P/E ratio as of December 2025 (TTM): -12.1

According to STAAR Surgical's latest financial reports and stock price the company's current price-to-earnings ratio (TTM) is -12.0718. At the end of 2024 the company had a P/E ratio of -59.2.

P/E ratio history for STAAR Surgical from 2001 to 2025

PE ratio at the end of each year

Year P/E ratio Change
2024-59.2-185.42%
202369.415.74%
202259.9-65.87%
2021176-74.06%
2020677496.72%
2019113-64.45%
2018319-189.24%
2017-358869.18%
2016-36.9-17.32%
2015-44.612.66%
2014-39.6-102.45%
2013> 1000-1161.64%
2012-152

P/E ratio for similar companies or competitors

Company P/E ratio P/E ratio differencediff. Country
SurgePays
SURG
-0.9297-92.30%๐Ÿ‡บ๐Ÿ‡ธ USA
Cooper Companies
COO
38.2-416.18%๐Ÿ‡บ๐Ÿ‡ธ USA
Atrion
ATRI
29.9-348.04%๐Ÿ‡บ๐Ÿ‡ธ USA
Abbott Laboratories
ABT
15.2-225.53%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
17.7-246.51%๐Ÿ‡จ๐Ÿ‡ญ Switzerland

How to read a P/E ratio?

The Price/Earnings ratio measures the relationship between a company's stock price and its earnings per share. A low but positive P/E ratio stands for a company that is generating high earnings compared to its current valuation and might be undervalued. A company with a high negative (near 0) P/E ratio stands for a company that is generating heavy losses compared to its current valuation.

Companies with a P/E ratio over 30 or a negative one are generaly seen as "growth stocks" meaning that investors typically expect the company to grow or to become profitable in the future.
Companies with a positive P/E ratio bellow 10 are generally seen as "value stocks" meaning that the company is already very profitable and unlikely to strong growth in the future.